Document is current
Any future updates will be listed below
-
Authors
Laurie, Sonia J. https://orcid.org/0000-0003-1509-6407
Foster, Joseph P. II
Bruce, Danny W.
Bommiasamy, Hemamalini
Kolupaev, Oleg V.
Yazdimamaghani, Mostafa
Pattenden, Samantha G.
Chao, Nelson J. https://orcid.org/0000-0001-6725-7220
Sarantopoulos, Stefanie https://orcid.org/0000-0003-4551-6687
Parker, Joel S. https://orcid.org/0000-0003-2080-6901
Davis, Ian J.
Serody, Jonathan S. https://orcid.org/0000-0003-4568-1092
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1R01HL139730-03, 1R01HL155098-01A1)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1T32CA211056-01A1, R01CA276663)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1K12GM000678-20, T32GM067553, R01GM138912)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 25 April 2023
Accepted: 2 July 2024
First Online: 17 July 2024
Competing interests
: J.S.S. has received research funding from Merck Inc., Carisma Therapeutics, and Glaxo Smith Kline and is a compensated consultant for PIQUE Therapeutics. J.S.S./D.B. Intellectual Property: 16,598,914, D.B./J.S.S.: US patent 11,471,517. S.G.P. and I.J.D. own equity in Triangle Biotechnology, Inc. S.G.P. is an inventor of Intellectual Property related to this research that is licensed to Triangle Biotechnology, Inc. from the University of North Carolina at Chapel Hill. The remaining authors declare no competing interests.
